Duchenne Muscular Dystrophy Global Market Report 2024

Global Duchenne Muscular Dystrophy Market Report 2024

Duchenne Muscular Dystrophy Global Market Report 2024 – By Therapy (Mutation Suppression, Exon Skipping Approach), By Therapeutic Class (Molecular Based Therapies, Steroid Therapy), By Route of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Duchenne Muscular Dystrophy Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Duchenne Muscular Dystrophy Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Duchenne Muscular Dystrophy Global Market Report 2023

Proud Members Of

Duchenne Muscular Dystrophy Market Definition

Duchenne muscular dystrophy is a genetic disease that causes gradual muscle loss, affecting the skeletal, cardiac, and lung muscles. It is caused by a mutation in the gene responsible for producing dystrophin, a protein that is crucial for the healthy operation of muscles.

The main types of therapies included in duchenne muscular dystrophy are mutation suppression and exon skipping approach. Exon skipping is the most prevalent type of alternative splicing, in which introns and intervals on a pre-mRNA molecule that ordinarily function as exons of a gene are removed together when a final mRNA is formed. therapeutic classes included are molecular-based therapies and steroid therapy and the route of administration are oral, parenteral, and others. These are distributed through hospital pharmacies, online pharmacies, and retail pharmacies for use in end-users such as hospitals, homecare, specialty clinics, and others.

Duchenne Muscular Dystrophy Market Segmentation

The duchenne muscular dystrophy market covered in this report is segmented –

1) By Therapy: Mutation Suppression, Exon Skipping Approach

2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy

3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Global Duchenne Muscular Dystrophy Market Size 2023 to 2028: Graph

Duchenne Muscular Dystrophy Market Size 2024 And Growth Rate

The duchenne muscular dystrophy market size has grown strongly in recent years. It will grow from $1.07 billion in 2023 to $1.17 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to genetic understanding and diagnostic advances, clinical trial progress, patient advocacy and awareness, orphan drug designation and incentives, collaborative research initiatives.

Duchenne Muscular Dystrophy Market Growth Forecast

The duchenne muscular dystrophy market size is expected to see strong growth in the next few years. It will grow to $1.61 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to emerging gene therapies, precision medicine approaches, expanded access to therapies, long-term follow-up studies, regulatory advancements. Major trends in the forecast period include integration of digital health technologies, technological advancements in therapeutics, gene therapies and genetic medicines, regulatory support for orphan drugs, precision medicine approaches.

Book your 30 minutes free consultation with our research experts

Duchenne Muscular Dystrophy Market Driver: The Role Of Duchenne Muscular Dystrophy Market In Chronic Disease Landscape

The increasing prevalence of chronic diseases is expected to propel the growth of the Duchenne muscular dystrophy market in the future. A chronic disease is a health issue or condition with long-lasting symptoms lasting for at least a year. The Duchenne muscular dystrophy contributes to the prevalence of chronic diseases by addressing the specific therapeutic needs of individuals with this genetic disorder, highlighting the broader significance of personalized medicine in managing and potentially mitigating the impact of chronic conditions. For instance, in January 2023, according to the National Institutes of Health (NIH), a U.S. government agency that conducts and supports biomedical and health-related research, the study projects a substantial rise in the prevalence of chronic diseases among the working-age population in the United States, with an estimated 99.5% increase in adults aged 50 years and older with at least one chronic disease from 2020 to 2035. Additionally, the prevalence of multimorbidity is expected to surge by 110.5% from 2020 to 2050, highlighting the growing health challenges faced by the working population. Therefore, the increasing prevalence of chronic diseases is driving the growth of the Duchenne muscular dystrophy market.

Duchenne Muscular Dystrophy Market Driver: Personalized Medicine's Impact On Duchenne Muscular Dystrophy Market

The growing demand for personalized medicine is expected to propel the Duchenne muscular dystrophy market's growth in the future. Personalized medicine tailors medical treatment to an individual's unique characteristics, such as genetic makeup or lifestyle, resulting in more effective and precise healthcare outcomes. Personalized medicine is used to manage Duchenne muscular dystrophy (DMD), by tailoring treatments based on individual factors advances therapeutic efficacy and improves patient outcomes. For instance, in December 2023, according to a report by The Personalized Medicine Coalition (PMC), a US-based nonprofit organization that promotes the use of personalized medicine concepts, services, and products, personalized medicines constituted 35% of newly approved NMEs in 2021. They have consistently represented over a quarter of new therapeutics approved since 2015. Over the last six years, personalized medicines have consistently comprised more than a third of new drug approvals. Therefore, the growing demand for personalized medicine is driving the Duchenne muscular dystrophy market's growth.

Global Duchenne Muscular Dystrophy Market Major Players

Major companies operating in the duchenne muscular dystrophy market report are Pfizer Inc., GlaxoSmithKline plc, Eli Lilly and Company, Daiichi Sankyo Company Limited, PerkinElmer Inc., BioMarin Pharmaceutical Inc., Nippon Shinyaku Co. Ltd., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Acceleron Pharma Inc., FibroGen Inc., Asklepios BioPharmaceutical Inc., Catabasis Pharmaceuticals Inc., Wave Life Sciences Ltd., Bristol Myers Squibb Company, BridgeBio Pharma Inc., CureVac N.V., Rocket Pharmaceuticals Inc., Italfarmaco SpA, Solid Biosciences Inc., Avidity Biosciences Inc., Fulcrum Therapeutics Inc., Akashi Therapeutics Inc., Nihon Pharmaceutical Co. Ltd., WAVE Life Sciences Ltd., Capricor Therapeutics Inc., Santhera Pharmaceuticals Holding, Armagen Technologies Inc., Dyne Therapeutics Inc., Benitec Biopharma Limited, Edgewise Therapeutics Inc.

Global Duchenne Muscular Dystrophy Market Trend: Technological Advancements Drive Growth In Duchenne Muscular Dystrophy Market

Technological advancements are a key trend gaining popularity in the Duchenne muscular dystrophy market. Major companies operating in the Duchenne muscular dystrophy market are focusing more on technological advancements and research and development to sustain their position in the market. For instance, in April 2021, according to the University of Texas Southwestern's s Hamon Center for Regenerative Science and Medicine, a US-based public academic health science center, launched a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD) by using CRISPR-Cas9-based techniques to restore a significant portion of the dystrophin protein that is missing in many DMD patients. The scientists created several effective CRISPR-Cas9 nucleotide gene editing techniques to bypass the mistaken stop signal, restoring the creation of 97 % of the protein. They quickly investigated nucleotide gene editing techniques using cardiomyocytes produced from iPS cells of DMD patients, showing the restoration of the dystrophin protein.

Global Duchenne Muscular Dystrophy Market Trend: Pioneering Gene Therapy For Duchenne Muscular Dystrophy Marks A Revolutionary Milestone In Treatment Innovation

Major companies operating in the Duchenne muscular dystrophy market are focusing on product innovations, such as the first gene therapy to treat Duchenne Muscular Dystrophy. This therapy involves introducing functional copies of the dystrophin gene into affected individuals to address the genetic mutation responsible for the progressive muscle degeneration characteristic of the disease. For instance, in June 2023, Sarepta Therapeutics, a US-based biopharmaceutical company that develops RNA-based treatments for rare and infectious diseases, announced FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy. This groundbreaking one-time treatment utilizes advanced gene therapy technology to address the genetic cause of the disease. Its significance lies in revolutionizing DMD treatment, representing a breakthrough from traditional supportive care approaches, potentially enhancing patients' quality of life and life expectancy while showcasing the transformative potential of gene therapy in addressing rare diseases.

Duchenne Muscular Dystrophy Market Merger And Acquisition:

Solid Biosciences Expands Neuromuscular And Cardiac Programs Through Acquisition Of AavantiBio

In December 2022, Solid Biosciences, a US-based based life sciences company focused on developing on advancing a portfolio of neuromuscular and cardiac programs acquired AavantiBio for an undisclosed amount. With this acquisition, the combined company will focus on developing variety of neuromuscular and cardiac programs, including SGT-003, Solid's next-generation gene transfer candidate for the treatment of Duchenne. AavantiBio, Inc. is a US-based biotechnology company focused on developing gene therapies to transform the lives of patients with rare genetic diseases.

Regional Insights For The Global Duchenne Muscular Dystrophy Market

North America was the largest region in the Duchenne muscular dystrophy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global duchenne muscular dystrophy market during the forecast period. The regions covered in the duchenne muscular dystrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the duchenne muscular dystrophy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The duchenne muscular dystrophy market includes revenues earned by entities by providing respiratory therapy, physical therapy and gene therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The duchenne muscular dystrophy market research report is one of a series of new reports from The Business Research Company that provides Duchenne muscular dystrophy optical components market statistics, including Duchenne muscular dystrophy optical components industry global market size, regional shares, competitors with a Duchenne muscular dystrophy optical components market share, detailed Duchenne muscular dystrophy optical components market segments, market trends, and opportunities, and any further data you may need to thrive in the Duchenne muscular dystrophy optical components industry. This Duchenne muscular dystrophy optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Duchenne Muscular Dystrophy Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$1.17 billion
Revenue Forecast In 2033	$1.61 billion
Growth Rate	CAGR of 8.2% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Therapy: Mutation Suppression, Exon Skipping Approach 2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy 3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; GlaxoSmithKline plc; Eli Lilly and Company; Daiichi Sankyo Company Limited; PerkinElmer Inc.; BioMarin Pharmaceutical Inc.; Nippon Shinyaku Co. Ltd.; Sarepta Therapeutics Inc.; PTC Therapeutics Inc.; Acceleron Pharma Inc.; FibroGen Inc.; Asklepios BioPharmaceutical Inc.; Catabasis Pharmaceuticals Inc.; Wave Life Sciences Ltd.; Bristol Myers Squibb Company; BridgeBio Pharma Inc.; CureVac N.V.; Rocket Pharmaceuticals Inc.; Italfarmaco SpA; Solid Biosciences Inc.; Avidity Biosciences Inc.; Fulcrum Therapeutics Inc.; Akashi Therapeutics Inc.; Nihon Pharmaceutical Co. Ltd.; WAVE Life Sciences Ltd.; Capricor Therapeutics Inc.; Santhera Pharmaceuticals Holding; Armagen Technologies Inc.; Dyne Therapeutics Inc.; Benitec Biopharma Limited; Edgewise Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Duchenne Muscular Dystrophy Market Characteristics

3. Duchenne Muscular Dystrophy Market Trends And Strategies

4. Duchenne Muscular Dystrophy Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Duchenne Muscular Dystrophy Market Size and Growth

5.1. Global Duchenne Muscular Dystrophy Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Duchenne Muscular Dystrophy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Duchenne Muscular Dystrophy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Duchenne Muscular Dystrophy Market Segmentation

6.1. Global Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Mutation Suppression

Exon Skipping Approach

6.2. Global Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Molecular Based Therapies

Steroid Therapy

6.3. Global Duchenne Muscular Dystrophy Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oral

Parenteral

Other Routes Of Administration

6.4. Global Duchenne Muscular Dystrophy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

6.5. Global Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

7. Duchenne Muscular Dystrophy Market Regional And Country Analysis

7.1. Global Duchenne Muscular Dystrophy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Duchenne Muscular Dystrophy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Duchenne Muscular Dystrophy Market

8.1. Asia-Pacific Duchenne Muscular Dystrophy Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Duchenne Muscular Dystrophy Market

9.1. China Duchenne Muscular Dystrophy Market Overview

9.2. China Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Duchenne Muscular Dystrophy Market

10.1. India Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Duchenne Muscular Dystrophy Market

11.1. Japan Duchenne Muscular Dystrophy Market Overview

11.2. Japan Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Duchenne Muscular Dystrophy Market

12.1. Australia Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Duchenne Muscular Dystrophy Market

13.1. Indonesia Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Duchenne Muscular Dystrophy Market

14.1. South Korea Duchenne Muscular Dystrophy Market Overview

14.2. South Korea Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Duchenne Muscular Dystrophy Market

15.1. Western Europe Duchenne Muscular Dystrophy Market Overview

15.2. Western Europe Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Duchenne Muscular Dystrophy Market

16.1. UK Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Duchenne Muscular Dystrophy Market

17.1. Germany Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Duchenne Muscular Dystrophy Market

18.1. France Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Duchenne Muscular Dystrophy Market

19.1. Italy Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Duchenne Muscular Dystrophy Market

20.1. Spain Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Duchenne Muscular Dystrophy Market

21.1. Eastern Europe Duchenne Muscular Dystrophy Market Overview

21.2. Eastern Europe Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Duchenne Muscular Dystrophy Market

22.1. Russia Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Duchenne Muscular Dystrophy Market

23.1. North America Duchenne Muscular Dystrophy Market Overview

23.2. North America Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Duchenne Muscular Dystrophy Market

24.1. USA Duchenne Muscular Dystrophy Market Overview

24.2. USA Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Duchenne Muscular Dystrophy Market

25.1. Canada Duchenne Muscular Dystrophy Market Overview

25.2. Canada Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Duchenne Muscular Dystrophy Market

26.1. South America Duchenne Muscular Dystrophy Market Overview

26.2. South America Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Duchenne Muscular Dystrophy Market

27.1. Brazil Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Duchenne Muscular Dystrophy Market

28.1. Middle East Duchenne Muscular Dystrophy Market Overview

28.2. Middle East Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Duchenne Muscular Dystrophy Market

29.1. Africa Duchenne Muscular Dystrophy Market Overview

29.2. Africa Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Duchenne Muscular Dystrophy Market Competitive Landscape And Company Profiles

30.1. Duchenne Muscular Dystrophy Market Competitive Landscape

30.2. Duchenne Muscular Dystrophy Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. GlaxoSmithKline plc

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Eli Lilly and Company

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Daiichi Sankyo Company Limited

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. PerkinElmer Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Duchenne Muscular Dystrophy Market Other Major And Innovative Companies

31.1. BioMarin Pharmaceutical Inc.

31.2. Nippon Shinyaku Co. Ltd.

31.3. Sarepta Therapeutics Inc.

31.4. PTC Therapeutics Inc.

31.5. Acceleron Pharma Inc.

31.6. FibroGen Inc.

31.7. Asklepios BioPharmaceutical Inc.

31.8. Catabasis Pharmaceuticals Inc.

31.9. Wave Life Sciences Ltd.

31.10. Bristol Myers Squibb Company

31.11. BridgeBio Pharma Inc.

31.12. CureVac N.V.

31.13. Rocket Pharmaceuticals Inc.

31.14. Italfarmaco SpA

31.15. Solid Biosciences Inc

32. Global Duchenne Muscular Dystrophy Market Competitive Benchmarking

33. Global Duchenne Muscular Dystrophy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Duchenne Muscular Dystrophy Market

35. Duchenne Muscular Dystrophy Market Future Outlook and Potential Analysis

35.1 Duchenne Muscular Dystrophy Market In 2028 - Countries Offering Most New Opportunities

35.2 Duchenne Muscular Dystrophy Market In 2028 - Segments Offering Most New Opportunities

35.3 Duchenne Muscular Dystrophy Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Duchenne Muscular Dystrophy Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Duchenne Muscular Dystrophy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Duchenne Muscular Dystrophy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Global Duchenne Muscular Dystrophy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: Asia-Pacific, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: China, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: India, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Japan, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Australia, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: Indonesia, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: South Korea, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: Western Europe, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: UK, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: Germany, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: France, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Italy, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Spain, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Eastern Europe, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: Russia, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: North America, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: USA, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: Canada, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: South America, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Brazil, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Middle East, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Africa, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 76: Pfizer Inc. Financial Performance

Table 77: GlaxoSmithKline plc Financial Performance

Table 78: Eli Lilly and Company Financial Performance

Table 79: Daiichi Sankyo Company Limited Financial Performance

Table 80: PerkinElmer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Duchenne Muscular Dystrophy Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Duchenne Muscular Dystrophy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Duchenne Muscular Dystrophy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Global Duchenne Muscular Dystrophy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: Asia-Pacific, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: China, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: India, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Japan, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Australia, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: Indonesia, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: South Korea, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: Western Europe, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: UK, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: Germany, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: France, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Italy, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Spain, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Eastern Europe, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: Russia, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: North America, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: USA, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: Canada, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: South America, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Brazil, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Middle East, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Duchenne Muscular Dystrophy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Duchenne Muscular Dystrophy Market, Segmentation By Therapeutic Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Africa, Duchenne Muscular Dystrophy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 76: Pfizer Inc. Financial Performance

Figure 77: GlaxoSmithKline plc Financial Performance

Figure 78: Eli Lilly and Company Financial Performance

Figure 79: Daiichi Sankyo Company Limited Financial Performance

Figure 80: PerkinElmer Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Generic Musculoskeletal Disorders Drugs Global Market Report 2024 – By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Muscle Relaxant Drugs Global Market Report 2024 – By Drug Type( Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Formulation( Cyclobenzaprine, Carisoprodol, Chlorzoxazone, Metaxalone, Methocarbamol, Baclofen, Tizanidine, Orphenadrine, Dantrolene ), By Route of Administration( Oral, Injectable, Spray, Ointment), By End-User( Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Women’s Health Devices Global Market Report 2024 – By Product (Surgical, Diagnostics, Contraceptives, Labor and Delivery, Critical Care), By Type (Devices, Consumables), By Application (Cancer, Osteoporosis, Infectious Disease, Uterine Fibroids, Post-menopausal Syndrome, Pregnancy, Female Sterilization, Other Applications), By End-user (Hospitals, Obstetrics and Gynecology Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Home Health Care And Residential Nursing Care Services Global Market Report 2024 – By Type (Home Health Care Providers, Retirement Communities, Nursing Care Facilities, Orphanages & Group Homes), By Type of Expenditure (Public, Private), By End User Gender (Male, Female) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Physicians And Other Health Practitioners Global Market Report 2024 – By Type (Specialist Doctors, Primary Care Doctors, Podiatrists, Physical Therapists, Optometrists, Chiropractors), By End User Gender (Male, Female), By Type of Expenditure (Public, Private) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Connected Healthcare Global Market Report 2024 – By Type (e-Prescription, mHealth Services, mHealth Devices ), By Function (Remote Patient Monitoring, Clinical Monitoring, Telemedicine, Other Functions ), By Application (Monitoring Applications, Diagnosis And Treatment, Education And Awareness, Healthcare Management, Wellness And Prevention ), By End Users (Hospitals And Clinics, Home Monitoring) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pharmacies and Healthcare Stores Global Market Report 2024 – By Type (Pharmacies And Drug Stores, Food (Health) Supplement Stores, Other Healthcare And Personal Care Stores), By Ownership (Retail Chain, Independent Stores), By drug type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Healthcare Services Global Market Report 2024 – By Type (Medical And Diagnostic Laboratory Services, Dental Services, Home Health Care And Residential Nursing Care Services, Residential Substance Abuse And Mental Health Facilities, Hospitals And Outpatient Care Centers, Physicians And Other Health Practitioners, All Other Ambulatory Health Care Services, Ambulance Services), By End User Gender (Male, Female), By Type of Expenditure (Public, Private) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the duchenne muscular dystrophy market?

How will the duchenne muscular dystrophy market drivers and restraints affect the duchenne muscular dystrophy market dynamics? What forces will shape the duchenne muscular dystrophy industry going forward?

The duchenne muscular dystrophy market major growth driver - the role of duchenne muscular dystrophy market in chronic disease landscape. For further insights on the duchenne muscular dystrophy market, request a sample here

What is the forecast market size or the forecast market value of the duchenne muscular dystrophy market ?

The duchenne muscular dystrophy market size has grown strongly in recent years. It will grow from $1.07 billion in 2023 to $1.17 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to genetic understanding and diagnostic advances, clinical trial progress, patient advocacy and awareness, orphan drug designation and incentives, collaborative research initiatives. The duchenne muscular dystrophy market size is expected to see strong growth in the next few years. It will grow to $1.61 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to emerging gene therapies, precision medicine approaches, expanded access to therapies, long-term follow-up studies, regulatory advancements. Major trends in the forecast period include integration of digital health technologies, technological advancements in therapeutics, gene therapies and genetic medicines, regulatory support for orphan drugs, precision medicine approaches. For further insights on the duchenne muscular dystrophy market, request a sample here

How is the duchenne muscular dystrophy market segmented?

The duchenne muscular dystrophy market is segmented
1) By Therapy: Mutation Suppression, Exon Skipping Approach
2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy
3) By Route of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-UsersFor further insights on the duchenne muscular dystrophy market, request a sample here

Which region has the largest share of the duchenne muscular dystrophy market? What are the other regions covered in the report?

North America was the largest region in the Duchenne muscular dystrophy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global duchenne muscular dystrophy market during the forecast period. The regions covered in the duchenne muscular dystrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the duchenne muscular dystrophy market, request a sample here.

Who are the major players in the duchenne muscular dystrophy market?

What are the key trends in the duchenne muscular dystrophy market?

Major trend in the duchenne muscular dystrophy market - pioneering gene therapy for duchenne muscular dystrophy marks a revolutionary milestone in treatment innovation. For further insights on the duchenne muscular dystrophy market, request a sample here.

What are the major opportunities in the duchenne muscular dystrophy market? What are the strategies for the duchenne muscular dystrophy market?

For detailed insights on the major opportunities and strategies in the duchenne muscular dystrophy market, request a sample here.

How does the duchenne muscular dystrophy market relate to the overall economy and other similar markets?

For detailed insights on duchenne muscular dystrophy market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the duchenne muscular dystrophy industry?

For detailed insights on the mergers and acquisitions in the duchenne muscular dystrophy industry, request a sample here.

What are the key dynamics influencing the duchenne muscular dystrophy market growth? SWOT analysis of the duchenne muscular dystrophy market.

For detailed insights on the key dynamics influencing the duchenne muscular dystrophy market growth and SWOT analysis of the duchenne muscular dystrophy industry, request a sample here.